Format

Send to

Choose Destination
Lancet. 2018 Sep 8;392(10150):798-800. doi: 10.1016/S0140-6736(18)32149-4.

Better and safer treatment for multidrug-resistant tuberculosis.

Author information

1
Harvard Medical School, Boston, MA 02115, USA; Brigham and Women's Hospital, Boston, MA, USA; Partners In Health, Boston, MA, USA. Electronic address: paul_farmer@hms.harvard.edu.
PMID:
30215368
DOI:
10.1016/S0140-6736(18)32149-4
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center